XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenue:        
Royalty and license fees $ 88,508 $ 62,433 $ 247,085 $ 189,430
Total revenue 88,508 62,433 247,085 189,430
Operating expenses:        
Cost of revenue 1,667 99 4,370 238
Research, development and other related costs 25,840 8,622 78,165 28,997
Selling, general and administrative 33,995 12,491 108,202 34,751
Amortization expense 27,769 6,052 84,475 18,126
Litigation expense 9,163 580 27,368 12,422
Total operating expenses 98,434 27,844 302,580 94,534
Operating income (loss) (9,926) 34,589 (55,495) 94,896
Interest expense (7,371) 0 (20,876) 0
Other income and expense, net 739 864 1,005 2,473
Income (loss) before taxes (16,558) 35,453 (75,366) 97,369
Provision for (benefit from) income taxes (4,442) 11,634 (13,164) 31,977
Net income (loss) $ (12,116) $ 23,819 $ (62,202) $ 65,392
Basic and diluted net income (loss) per share:        
Basic (in dollars per share) $ (0.24) $ 0.49 $ (1.26) $ 1.33
Diluted (in dollars per share) (0.24) 0.48 (1.26) 1.31
Cash dividends declared per share (in dollars per share) $ 0.20 $ 0.20 $ 0.6 $ 0.6
Weighted average number of shares used in per share calculations-basic (in shares) 49,469 48,545 49,293 49,096
Weighted average number of shares used in per share calculations-diluted (in shares) 49,469 49,304 49,293 49,803